At a glance
- Originator Mylan Pharmaceuticals
- Class Antipsoriatics; Antiretrovirals; Cyclopentanes; Cyclopropanes; Dideoxynucleosides; Small molecules
- Mechanism of Action Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections
Most Recent Events
- 26 Nov 2018 Abacavir (60mg) is not yet available in USA for HIV-1 infections (Mylan Pharmaceuticals website, November 2018)